Abiraterone acetate (ZYTIGA®)  -- Janssen CarePath

Afatinib (GILOTRIF®) -- Boehringer Ingelheim Solutions Plus™

Amivantamab-vmjw (RYBREVANT®)  -- Janssen CarePath

Apalutamide (ERLEADA®)  -- Janssen CarePath

Aprepitant (EMEND® for oral suspension) -- The Merck Access Program

avelumab (BAVENCIO®) -- CoverOne® (EMD Serono and Pfizer)

Axicabtagene ciloleucel (YESCARTA®)  -- Kite Konnect®, Kite, a Gilead Company

belinostat for injection (BELEODAQ®)  -- Acrotech Specialty Therapy Access Resources (STAR®) 

Brexucabtagene autoleucel (TECARTUS®)  -- Kite Konnect®, Kite, a Gilead Company

Cabazitaxel (Jevtana)  -- Sanofi CareASSIST

cabozantinib tablets (CABOMETYX®) -- Exelixis Access Services® (EASE)

Cemiplimab-rwlc (LIBTAYO®) -- LIBTAYO Surround®

Cerianna™ (fluoroestradiol F 18) Injection -- GE HealthCare Pharmaceutical Diagnostics

Daratumumab and hyaluronidase-fihj (DARZALEX FASPRO®)  -- Janssen CarePath

Daratumumab (DARZALEX®) -- Janssen CarePath

darolutamide (NUBEQA®) -- Access Services by BayerTM

dexamethasone tablets (HEMADY®)  -- Acrotech Specialty Therapy Access Resources (STAR®) 

Dostarlimab (​Jemperli)  -- GSK

Elacestrant (ORSERDU®) -- Stemline ARC®, Stemline Therapeutics Inc., a Menarini Group Company

Epoetin alfa (PROCRIT®) -- Janssen CarePath

erdafitinib (BALVERSA™) -- Janssen CarePath

Fosaprepitant (EMEND® for injection) -- The Merck Access Program

HALAVEN® (eribulin mesylate) injection, for intravenous use -- Eisai Assistance Program - Metastatic breast cancer who have previously received at least two chemotherapeutic regimens for the treatment of metastatic disease. Prior therapy should have included an anthracycline and a taxane in either the adjuvant or metastatic setting.

ibritumomab tiuxetan injection (ZEVALIN®)  -- Acrotech Specialty Therapy Access Resources (STAR®) 

Ibrutinib (IMBRUVICA®) By Your Side Patient Support -- Pharmacyclics LLC and Janssen Biotech, Inc.

isatuximab (Sarclisa)  -- Sanofi CareASSIST 

Lenvima (Lenvatinib®) -- For the first-line treatment of patients with unresectable hepatocellular carcinoma --- Eisai Assistance Program

levoleucovorin for injection (KHAPZORY™)  -- Acrotech Specialty Therapy Access Resources (STAR®) 

loncastuximab tesirine-lpyl (ZYNLONTA™) -- ADVANCING Patient Support | Personalized assistance from ADC Therapeutics

melphalan for injection (EVOMELA®)  -- Acrotech Specialty Therapy Access Resources (STAR®) 

Momelotinib (​Ojjaara) -- GSK

netupitant/fosnetupitant & palonosetron (AKYNZEO®)  -- Helsinn Cares

Niraparib and abiraterone acetate (AKEEGA™)  -- Janssen CarePath

Oncotype DX Breast Recurrence Score® -- Oncotype DX Genomic Access Program (GAP)

Oncotype DX Genomic Prostate Score® -- Oncotype DX Genomic Access Program (GAP)

Oncotype DX® Breast DCIS Score™ -- Oncotype DX Genomic Access Program (GAP)

Oncotype DX® Colon Recurrence Score™ -- Oncotype DX Genomic Access Program (GAP)

Pemigatinib (PEMAZYRE®)  -- IncyteCARES

pralatrexate injection (FOLOTYN®)  -- Acrotech Specialty Therapy Access Resources (STAR®) 

PYLARIFY® (piflufolastat F 18) injection, for intravenous use -- Lantheus

rasburicase (Elitek)  -- SanofiCareASSIST

Ruxolitinib (Jakafi®)  -- IncyteCARES

sacituzumab govetican-hziy (TRODELVY®) -- TRODELVY Access Support (Gilead™)

Siltuximab (SYLVANT®) -- Janssen CarePath

sipuleucel-T (PROVENGE®)  -- Dendreon on Call 

Tagraxofusp (ELZONRIS®) -- Stemline ARC®, Stemline Therapeutics Inc., a Menarini Group Company

Talquetamab-tgvs (TALVEY™)  -- Janssen CarePath

Teclistamab-cqyv (TECVAYLI®)  -- Janssen CarePath

Trabectedin (YONDELIS®) -- Janssen CarePath

Zanubrutinib (BRUKINSA®) -- myBeiGene® Patient Support

Zejula (niraparib) -- Together with GSK Oncology